Sign in

    L. Neil Hunn

    President and CEO at Roper Technologies Inc
    Board
    Since August 2018
    Age
    52 years
    Tenure
    Joined ROP in 2011 and served first as Group Vice President of the medical segment, later becoming Executive Vice President and Chief Operating Officer in 2017 before assuming the role of President and Chief Executive Officer in August 2018.

    Also at Roper Technologies Inc

    JPC
    Jason P. Conley
    EVP and CFO
    JKS
    John K. Stipancich
    EVP, General Counsel, and Corporate Secretary

    About

    L. Neil Hunn was born in 1972, and by his early fifties he has established a strong reputation as a dynamic leader in the technology and healthcare sectors. With his background in leading financial and operational functions, he has consistently demonstrated a focus on growth, strategic planning, and capital deployment across his career.

    Before joining ROP, he spent a decade at MedAssets, Inc., where he held key positions including Executive Vice President, Chief Financial Officer, and President of the revenue cycle technology businesses, successfully navigating an initial public offering and various mergers and acquisitions. His earlier professional experiences at companies such as CMGI, Inc. and Parthenon Group further enriched his expertise in technology and strategic consulting.

    Upon joining ROP in 2011, his contributions quickly became evident as he played a pivotal role in the expansion of the company’s medical segment. His career progression—from Group Vice President to Executive Vice President and Chief Operating Officer, and ultimately to President and CEO—underscores his ability to lead transformative initiatives and drive operational excellence. Beyond his executive roles at ROP, he has also been serving as a director of Deere & Company since 2023, broadening his leadership impact across industries.

    $ROP Performance Under L. Neil Hunn

    Past Roles

    OrganizationRoleDate RangeDetails
    Roper Technologies, Inc. Executive Vice President and Chief Operating Officer 2017–2018 Oversaw operations and drove strategic growth initiatives
    Roper Technologies, Inc. Group Vice President of Medical Segment 2011–2018 Led medical technology and application software businesses
    MedAssets, Inc. Executive Vice President, Chief Financial Officer, and later President of revenue cycle technology businesses N/A Led IPO and executed several M&A transactions; 10 years tenure
    CMGI, Inc. Various roles N/A Incubator of Internet businesses
    Parthenon Group Consultant N/A Strategy consulting firm experience

    External Roles

    OrganizationRoleDate RangeDetails
    Deere & Company Director Since 2023 Global leader in agricultural, construction, and forestry equipment

    Fixed Compensation

    Data from  FY 2023
    Component NameAmountPayment ScheduleAdditional Details
    Base Salary$1,000,000 2023Fixed annual base salary
    Club Memberships$11,931 2023Incremental cost to the company
    Personal Use of Aircraft$225,000 2023Incremental cost to the company
    Company Car$24,000 2023Incremental cost to the company
    Additional Medical Services$4,500 2023Incremental cost to the company
    Financial Planning$21,780 2023Incremental cost to the company
    Contributions to Defined Contribution Plans$225,000 2023Includes contributions to the Non-Qualified Retirement Plan and 401(k)

    Performance Compensation

    Data from  FY 2023

    Performance-Based Equity Incentive Awards

    MetricDetails
    Performance MetricAdjusted EBITDA measured cumulatively over a 36-month period (January 2023 – December 2025)
    Threshold$6.517 billion at which 17.5% of the award vests
    Target$6.917 billion at which 50% of the award vests, with pro-rata vesting between threshold and target
    Vesting ScheduleVests in March 2026, contingent upon performance certification by the Compensation Committee
    Grant DateMarch 14, 2023
    Grant Date Fair Value (Stock Awards)$13,982,907
    Grant Date Stock Price$428.07 per share
    Number of Shares Granted32,665 shares
    Vesting ConditionsPerformance criteria based on cumulative adjusted EBITDA must be met; dividends on restricted shares are paid only if the performance criteria are achieved

    This table outlines the detailed performance compensation components including metrics, thresholds, targets, vesting schedule, evaluation period, and key grant details for 2023.